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Abstract
Background:  Spontaneous repair is limited after CNS injury or degeneration because
neurogenesis and axonal regrowth rarely occur in the adult brain. As a result, cell transplantation
has raised much interest as potential treatment for patients with CNS lesions. Several types of cells
have been considered as candidates for such cell transplantation and replacement therapies. Foetal
brain tissue has already been shown to have significant effects in patients with Parkinson's disease.
Clinical use of the foetal brain tissue is, however, limited by ethical and technical problems as it
requires high numbers of grafted foetal cells and immunosuppression. Alternatively, several reports
suggested that mesenchymal stem cells, isolated from adult bone marrow, are multipotent cells and
could be used in autograft approach for replacement therapies.
Results: In this study, we addressed the question of the possible influence of mesenchymal stem
cells on neural stem cell fate. We have previously reported that adult rat mesenchymal stem cells
are able to express nestin in defined culture conditions (in the absence of serum and after 25 cell
population doublings) and we report here that nestin-positive (but not nestin-negative)
mesenchymal stem cells are able to favour the astroglial lineage in neural progenitors and stem cells
cultivated from embryonic striatum. The increase of the number of GFAP-positive cells is
associated with a significant decrease of the number of Tuj1- and O4-positive cells. Using
quantitative RT-PCR, we demonstrate that mesenchymal stem cells express LIF, CNTF, BMP2 and
BMP4 mRNAs, four cytokines known to play a role in astroglial fate decision. In this model, BMP4
is responsible for the astroglial stimulation and oligodendroglial inhibition, as 1) this cytokine is
present in a biologically-active form only in nestin-positive mesenchymal stem cells conditioned
medium and 2) anti-BMP4 antibodies inhibit the nestin-positive mesenchymal stem cells
conditioned medium inducing effect on astrogliogenesis.
Conclusions: When thinking carefully about mesenchymal stem cells as candidates for cellular
therapy in neurological diseases, their effects on resident neural cell fate have to be considered.
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Background
During development of the central nervous system (CNS),
all types of neuronal and macroglial cells derive from neu-
roepithelial neural stem cells (NSCs) [1,2]. NSCs self-
renew and continue to function as source of new cells in
adults [3,4]. The fate determination of neural stem cells is
regulated by cell-intrinsic programs as well as extrinsic
cues from the surrounding environment [5]. In the adult,
the molecular mechanisms that regulate the production of
new neurons in the dentate gyrus or in the subventricular
zone are still unknown, although extrinsic factors
expressed for example by astrocytes could play a role [6].
BMPs (Bone Morphogenetic Proteins) are secreted mem-
bers of the TGF-β superfamily. Together with their recep-
tors, they are abundantly expressed in the brain both
during embryogenesis and in the adult [7-9]. More specif-
ically, an expression of BMP4 was demonstrated in differ-
ent cell types like ectodermal cells [10], radial glia [11],
haematopoietic cells [12], chondrocytes [13] and stromal
cells [14]. As for other members of the TGF-β superfamily,
BMPs signal transduction is triggered by binding to type 1
and type 2 serine-threonine kinase receptors, inducing
their dimerization. In this manner, BMP2 and BMP4 sig-
nalling specifically leads to the formation of BMPR-1A/
BMPR-II and BMPR-1B/BMPR-II heterodimers [15]. BMPs
have been shown to play a role in patterning and cellular
fate determination in many tissues [16]. For examples,
during development, BMPs are involved in the induction
of the neuroectoderm, the patterning of the dorsal roof of
neural tube, the development of neural crests and of the
peripheral nervous system [10,17-20]. In postnatal ani-
mals, they promote the differentiation of neuronal precur-
sors in the spinal cord [21] and in the cortex [22,23].
Finally, they facilitate an astroglial lineage commitment of
forebrain subventricular zone progenitor cells [24].
Cellular therapies using stem cells are promising
approaches for the treatment of several chronic or acute
neurological diseases such as Parkinson's [25] or Hunting-
ton's diseases [26] or spinal cord injuries [27]. One main
problem relates to the origin and the nature of the cells to
be used for such procedures. Foetal brain tissue has
already been shown to have significant effects in patients
with Parkinson's disease. Clinical use of the foetal brain
tissue is, however, limited by ethical and technical prob-
lems as it requires high numbers of grafted foetal cells and
a possible immunosuppression. Alternatively, somatic
stem cells derived from adult tissues seem to be better can-
didates for cell replacement therapy [28,29]. These obser-
vations raise hopes in cell replacement strategies based on
an autograft approach. However, the exact mechanism by
which mesenchymal stem cells (MSCs) adopt a neural fate
is not completely understood as recent in vivo studies
demonstrated that MSCs fuse with host neuronal cells
[30,31]. These observations impose a better knowledge of
the mechanisms underlying the phenotypic plasticity of
somatic stem cells and the characterization of their daugh-
ter differentiated cells is a prerequisite before considering
their use in the treatment of human patients.
Recently, we demonstrated that two phenotypes of MSCs
could be obtained in culture: nestin-positive MSCs (npM-
SCs) which are able to integrate some extrinsic signals
when co-cultured with neurons leading to a differentia-
tion into astrocyte-like cells and nestin-negative MSCs
(nnMSCs) which are unable to adopt a neural phenotype
but remain able to differentiate into adipocytes, chondro-
cytes or osteocytes [32]. When considering the use of
MSCs as a source of material for cell replacement proto-
cols in neurological diseases, one has also to be concerned
by a possible effect of these MSCs on the host nervous tis-
sue and more particularly on immature resident neural
cells. In several models of neurological diseases, grafted
MSCs were shown to favour host CNS regeneration rather
than to express themselves a neural phenotype [33,34].
This positive effect of MSC grafts could result from the
release of factors acting on resident immature cells in the
adult brain. Recently, it has been demonstrated that fol-
lowing ischemia in the adult striatum, intra-ventricular
EGF injections are able to stimulate neurogenesis from
resident neural stem cells, although EGF is devoid of any
effect in non-ischemic striatum [35]. These observations
emphase the importance of the lesion priming in order to
respond to extrinsic factors or cytokines. In this paper, we
address the question of the influence of MSCs on neural
stem cells in vitro and demonstrate that MSCs favour astro-
glial lineage. We observe that npMSCs are able to stimu-
late astroglial fate in striatal progenitor cultures and to
repress neuronal and oligodendroglial fate through the
release of diffusible factor(s). Using BrdU incorporation,
we demonstrate that this npMSC conditioned medium
has no effect on the astrocytic or oligodendrocytic progen-
itor proliferation. Propidium iodide incorporations sug-
gest that the npMSCs conditioned medium protect GFAP-
positive cells from cell death in comparison to the effect
of nnMSCs conditioned medium or to the control condi-
tion. Meanwhile, no increase of cell death is observed in
neuronal and oligodendroglial populations. We then
demonstrated that BMP4 is present in a biologically-active
form in the npMSCs but not in nnMSCs conditioned
medium and is responsible for both the increase of astro-
glial numbers and the inhibition of oligodendrocyte dif-
ferentiation in striatal NSC cultures.
Results
Nestin-positive MSCs increase astrocytes number in 
differentiating neural stem cell cultures
Neurosphere-derived cells from GFP-positive E16 green
mouse striata include neural stem cells and progenitorsBMC Neuroscience 2004, 5:33 http://www.biomedcentral.com/1471-2202/5/33
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Nestin-positive MSCs increase astrocytes number in differentiating neural stem cell cultures Figure 1
Nestin-positive MSCs increase astrocytes number in differentiating neural stem cell cultures. Neurosphere-
derived GFP-expressing cells were co-cultivated with npMSCs or nnMSCs on polyornithine-coated dishes. After 5 days, the 
cells were fixed and immunostained with antibodies raised against GFAP (A, D, red), Tuj1 (B, E, red) and O4 (C, F, red). Nuclei 
were counterstained with EtD1 (blue). Co-cultures with npMSCs are illustrated in A (n = 12, ***Student T-test, P < 0.001), B 
(n = 12, ***Student T test, P < 0.0001) and C (n = 8, ***Student T test, P < 0.0001). Co-cultures with nnMSCs are illustrated 
in D (n = 8, Student T test, P > 0.05), E (n = 8, ***Student T test, P < 0.001) and F (n = 8, Student T test, P > 0.05). Stained cells 
counting results are shown in G and include the control condition of neurosphere-derived cells without co-culture. Scale bars 
= 20 µm in A-F.
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Tuj1 15.0 ± 2.1%   3.2 ± 1.1%    4.7 ± 0.8% 
O4     5.9 ± 0.6%     2.9 ± 0.5%   7.8 ± 1.5%
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which are still proliferating but already committed to a
given cell fate. Upon transfer on adherent surfaces (poly-
ornithine coated dishes), these cells spread and spontane-
ously differentiate as follows after 5 days of culture: 44.2
± 2.5% GFAP-positive cells (astroglial cells), 15 ± 2.1%
Tuj1-positive cells (neuronal cells) and 5.86 ± 0.6% 04-
positive cells (oligodendroglial cells). When co-cultivated
with nestin-positive MSCs (npMSCs), phenotypic alloca-
tion of neurosphere-derived cells (identified as GFP-posi-
tive cells) become strikingly different: GFAP labelling is
increased to 78.5 ± 3.9% (Fig. 1A) (n = 12, ***Student T-
test, P < 0.001), while Tuj-1 and O4 are decreased to
respectively 3.2 ± 1.1% (Fig. 1B) (n = 12, ***Student T
test, P < 0.0001) and 2.9 ± 0.5% (Fig. 1C) (n = 8, ***Stu-
dent T test, P < 0.0001). On the other hand, if neuro-
spheres are co-cultured with nestin-negative MSCs
(nnMSCs), the percentage of labelled cells were 52.1 ±
2.9%, 4.7 ± 0.8% and 7.8 ± 1.5 for respectively GFAP, Tuj-
1 and O4. These numbers are not significantly different
from the numbers obtained in control cultures for GFAP-
and O4-positive cells (n = 8, Student T test, P > 0.05),
while significantly lower for Tuj-1-postive cells (n = 8,
***Student T test, P < 0.001, Fig. 1G).
MSCs effect on neurospheres-derived astrocytes number is 
due to a soluble factor
To further characterize the mechanism (soluble factor ver-
sus membrane-bound factor) responsible for such an
increase in astrocytes number in presence of npMSCs, we
tried to induce the differentiation of neurospheres with
npMSC conditioned medium. The following data were
obtained: 77.5 ± 2.5% of the neurosphere-derived cells
became GFAP-positive, 4.3 ± 0.9% were Tuj1-positive and
1.5 ± 0.6% were 04-positive (n = 8, Fig. 2A,2B,2C). Con-
versely, in nnMSCs conditioned medium, differentiated
phenotypes were distributed as follows: 56 ± 3.5%, 3.7 ±
1.3% and 5.9 ± 1.3% (n = 7, Fig. 2G) and were similar to
results obtained in corresponding co-cultures. Moreover,
we confirmed those results by absolute count: 1) in npM-
SCs conditioned medium 392/504 cells were GFAP-posi-
tive, 9/504 cells were O4-positive and 32/504 cells were
Tuj1-positive ; 2) in nnMSCs conditioned medium 251/
515 cells were GFAP-positive, 29/515 were O4-positive
and 23/515 were Tuj1-positive; 3) in the control condi-
tion (DEM/F12 + B27), 211/531 cells were GFAP-positive,
27/531 cells were O4-positive and 167/531 cells were
Tuj1-positive. Hence, regarding the phenotypic alloca-
tion, no significant difference is observed between neuro-
sphere differentiated in co-culture and in conditioned
medium. (Student T test, P > 0.05). This clearly suggest
that npMSCs-derived soluble factor(s) is (are) responsible
for an increase in the astrocytes number and a decrease in
the neurons and oligodendrocytes numbers.
Nestin-positive MSC conditioned medium act on the 
GFAP-positve cell death
As mentioned above, neurosphere derived-cells include
neural stem cells and progenitors which are still prolifer-
ating but already committed to a given cell fate. We char-
acterised the proportion of each progenitor cell-type
present in our neurospheres. After dissociation, cells were
allowed to adhere for one hour in coated dish and then
fixed, labelled and counted. In those conditions we
observed 14.4 ± 7.1% of GFAP-positive cells, 7.1± 4.1% of
Tuj1-positive cells and 3.4 ± 1.6% of O4-positive cells
(these data were obtained by absolute counts on 1576
cells, Fig. 3A).
In order to define if npMSCs conditioned medium has an
instructive or/and a selective effect on neural cells, we ana-
lysed the proliferative capacity and the cell death in the
differentiating neurospheres. The BrdU incorporation in
differentiating neurosphere-derived cells cultivated in
npMSCs- or in nnMSCs-conditioned medium or in con-
trol (non-conditioned) medium (DEM/F12 + B27) did
not show any significant differences (Statistical test
ANOVA, P > 0.05, Fig. 3B,3C). These data rule out a pro-
liferative effect on already committed astrocyte progeni-
tors or an inhibition of cell proliferation in
oligodendroglial and neuronal progenitors. Furthermore,
using propidium iodide incorporations and counting, we
quantified the cell death in GFAP-, Tuj1- and O4-positive
cell population during the differentiation culture in the
three conditioned media (by npMSCs, by nnMSCs and
non-conditioned). After 48 hours, we observed a signifi-
cant decrease of the number of GFAP-positive cells which
have incorporated the propidium iodide in npMSCs-con-
ditioned medium (***Student T test, p < 0.0001) in com-
parison to the two other culture condition. This result
suggests that npMSC conditioned medium partially
inhibit the cell death in the GFAP-positive cell popula-
tion. Nevertheless, no significant increase of cell death is
observed in O4- and Tuj1-positive cell population (Stu-
dent T test, p > 0.05). When propidum iodide incorpora-
tions are performed after four days of differentiation
without renewing the conditioned media, no significant
differences in the cell death could be observed in the three
lineages, whatever the culture condition (Fig. 3D,3E).
BMP4 is present in nestin-positive conditioned medium 
and is responsible for the increase of GFAP-positive cells in 
differentiating NSCs
Previous reports have shown that several secreted growth
factors, including BMP2, BMP4, LIF and CNTF stimulate
the differentiation of cultured neural precursors into
astrocytes [36-41]. The expression of those cytokines was
compared in nnMSCs and in npMSCs using quantitative
RT-PCR. Compared to nnMSCs, we found that npMSCs
slightly increased the expression level of BMP4 mRNABMC Neuroscience 2004, 5:33 http://www.biomedcentral.com/1471-2202/5/33
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Humoral effect of nestin-positive MSCs Figure 2
Humoral effect of nestin-positive MSCs. Neurosphere-derived GFP-expressing cells were cultivated with npMSC or 
nnMSC conditioned media, on polyornithine-coated dishes. After 5 days, the cells were fixed and immunostained with antibod-
ies raised against GFAP (A, D, green), Tuj1 (B, E, green) and O4 (C, F, green). Nuclei were counterstained with EtD1 (red). 
Cultures with npMSC conditioned medium are illustrated in A, B and C. As observed in co-culture conditions, there is a signif-
icant increase of the number of GFAP-positive cells and significant decreases of the number of Tuj1-positive cells and O4-posi-
tive cells (n = 8, ***Student T test, P < 0.0001). Cultures with nnMSC conditioned medium are illustrated in D, E and F (n = 7, 
***Student T test, P < 0.0001). Stained cells counting results are shown in G and include the control condition of neurosphere-
derived cells without conditioned medium. No significant difference is observed between neurosphere differentiated in co-cul-
ture and in conditioned medium. (Student T test, P > 0.05). Scale bars = 20 µm in A-F.
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Nestin-positive MSC conditioned medium act on the GFAP-positive cell death but not on cell proliferation Figure 3
Nestin-positive MSC conditioned medium act on the GFAP-positive cell death but not on cell proliferation. (A) 
Characterization of committed cell types in proliferating neurospheres in presence of EGF. We observed that 14.4 ± 7.1%, 
7.1± 4.1% and 3.4 ± 1.6% of cells were respectively GFAP-, Tuj1- and O4-positive (these data were obtained by absolute 
counts on 1576 cells). (B-C) The proliferative capacity of the differentiating neurosphere-derived cells placed in npMSC condi-
tioned medium, nnMSC conditioned medium and in control medium (DEM/F12 + B27) was compared. BrdU incorporation was 
performed after 48 hours and 4 days in differentiating conditions. Double labelling GFAP-, Tuj1- and O4 with BrdU were per-
formed. The BrdU incorporation by differentiating neurosphere-derived cells placed in the various conditions did not shown 
significant differences (Statistical test ANOVA, P > 0.05). (D-E) The cell death quantified by propidium iodide incorporation 
and counting was analysed after 48 hours and 4 days in differentiating conditions and in GFAP-, Tuj1- and O4-positive cells. 
After 48 hours, a significant decrease of the number of GFAP-positive cells which have incorporated the propidium iodide is 
observed (***Student T test, p < 0.0001). However, no significant increase of cell death was observed in O4- and Tuj1-positive 
cell population (Student T test, p > 0.05). After 4 days of differentiation, no difference in cell death is observed whatever the 
cell type or the culture condition.
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(190 ± 26%) while the BMP2 (36 ± 7%) and LIF (50 ±
10%) expression is slightly decreased (Fig. 4A). No signif-
icant difference was observed concerning the CNTF
mRNA expression. Western blotting analyses of npMSCs,
nnMSCs and neurosphere-derived cells conditioned
media showed that only npMSCs release in their culture
medium the mature and biologically-active form of BMP4
(27 kDa), although nnMSCs and neurosphere-derived
cells expressed the biologically-inactive precursor form of
BMP4 (57 kDa) (Fig. 4B). Finally, we observed that neu-
rospheres-derived cells cultivated in npMSCs conditioned
medium supplemented with an anti-BMP4 blocking anti-
bodies, differentiate into 47.1 ± 1.5% GFAP-positive cells,
9.9 ± 0.9% Tuj1-positive cells and 5.7 ± 0.5% O4-positive
cells (Fig. 4C). Statistical analyses did not show significant
differences in GFAP- or O4-positive cells compared to
control culture conditions (student T test, p > 0.05, n = 5).
However, the number of Tuj1-positive cells remains sig-
nificantly lower (***student T test, p < 0.001, n = 5). We
thus conclude that the major glial effects (increase of
astrocytes and decrease of oligodendrocytes) of the npM-
SCs on the neural progenitor differentiation is due to the
release of biologically-active BMP4. The inhibition of neu-
ronal differentiation should be attributed to another yet
uncharacterized soluble factor(s).
Discussion
During the last few years, a number of studies have
addressed the phenotypic plasticity of MSCs. Most of
them were performed in vivo and demonstrated that envi-
ronmental factors play important roles in determining the
ability of grafted MSCs to adopt a neural-like phenotype.
Grafting of a subset of MSCs into the lateral ventricle of
neonatal mice resulted in their migration within the fore-
brain and cerebellum, and their differentiation into astro-
cytes [42]. When MSCs were grafted into adult rat
cerebellum after an ischemic lesion, they differentiated
into cells expressing neuronal markers [43]. Nakano et al.
[44] demonstrated that murine bone marrow cells differ-
entiated into three distinct glial phenotypes (oli-
godendrocytes, astrocytes and microglia) when they were
directly injected into the striatum of previously irradiated
mice. Similarly, systemic injection of MSCs in lethally
irradiated mice allowed their differentiation into neuro-
nal and astroglial cells [45]. Interestingly, the systemic
injection of MSCs in non-irradiated but brain-lesioned
mice had positive effects on injury repair, but very few
MSC-derived cells expressed neural marker in such condi-
tions [22,33,34,46,47]. Given those results, somatic stem
cells raise thus hopes in cell replacement strategies based
on an autograft approach. Recent in vivo studies [30,31]
demonstrated that MSCs adopt neural fate by fusion with
host neural cells. At least so far, there is no a clear and con-
clusive demonstration of a real differentiation of MSCs in
neural cells. However, all those data obtained in vivo
Release of an active form of BMP4 by nestin-positive MSCs Figure 4
Release of an active form of BMP4 by nestin-positive 
MSCs. (A)RT-PCR and quantitative RT-PCR were per-
formed on npMSCs and nnMSCs. The results of quantitative 
RT-PCR are expressed as percent of gene expression in 
npMSCs compared to nnMSCs (arbitrarily as 100%) after 
normalisation with the GAPDH house-keeping gene expres-
sion. (B) Western blotting analysis of conditioned media by 
npMSCs, nnMSCs and NSC. The mature and biologically-
active form of BMP4 (27 kDa) is only observed in medium 
conditioned by npMSCs and the 57 kDa immature and non 
biologically-active form can be seen in nnMSC and in neural 
stem cells conditioned medium. This high MW form is not 
present in npMSC conditioned medium, indicating a com-
plete cleavage and activation of BMP4. (C) Effect of anti-
BMP4 antibodies in differentiating NSCs cultivated in DEM/
F12 or npMSCs conditioned medium. Anti-BMP4 antibodies 
inhibit the npMSCs effect on astroglial and oligodendroglial 
cell numbers but not the effect on neurons number (47.13 ± 
1.53% of GFAP-positive cells, 9.98 ± 0.92% of Tuj1-positive 
cells and 5.67 ± 0.45% of O4-positive cells with anti-BMP4 
compared to respectively 77.5 ± 2.5%, 4.30 ± 0.95% and 
1.47± 0.60% in npMSC conditioned-medium). Tuj1-positive 
cells remains significantly lower (***student T test, p < 0.001, 
n = 5).
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suggested that somatic stem cells seem to be promising for
cellular therapy in neural diseases whatever the mecha-
nism responsible for. It remains that a better knowledge of
the molecular and cellular mechanism underlying the
neural phenotypic plasticity of MSCs is required before
considering those cells in human graft protocols.
As we mentioned above, environment is able to modify
the cellular differentiation capacity. In this study, we
addressed the question of a possible effect of MSCs on
neural progenitor cell fate and we choose an in vitro
approach. Co-culture experiments demonstrate that MSCs
display multiple activities in the regulation of embryonic
striatum-derived progenitors and stem cells. Their effect
mainly depends of their age in vitro: npMSCs (more than
10 passages in vitro or 25 doubling cell populations)
increase the astrocytes numbers while inhibiting neuronal
and oligodendroglial numbers. Conversely, nnMSCs
(with a maximum of 5 passages in vitro) only decrease the
neuronal differentiation. Since similar results were
obtained using MSC conditioned media, we concluded
that these effects could be mediated by diffusible fac-
tor(s). We then analysed the effect of various conditioned
media on the cell proliferation (using BrdU incorpora-
tion) as well as the cell death (using propidium iodide
incorporation) in each neurosphere-derived cell types and
at two different differentiation period (48 or 96 hours).
We only observed a significant decrease of propidium
iodide incorporation in GFAP-positive cell population at
48 hours of differentiation suggesting that soluble fac-
tor(s) select astroglial lineage by protecting those cells
from cell death.
The activity which drives neurosphere-derived cells into
astrocytes only occurs in npMSC conditioned medium
while the neuronal differentiation-inhibiting activity is
present both in np- and nnMSC conditioned media. We
tried to identify the astrogliogenetic factor(s) by measur-
ing the expression by nn- and npMSCs of cytokines
known to promote an astroglial fate [36-41]. Our results
show that only npMSCs express mature and biologically-
active BMP4 while a biologically-inactive BMP4 precursor
form is expressed and released by nnMSCs and neuro-
sphere-derived cells in culture. Indeed, BMP4 is synthe-
sized and released as an inactive precursor before being
proteolytically activated by cleavage at the amino acid
motif -Arg-Ser-Lys-Arg- [48]. Relatively little is known
about the regulatory mechanisms controlling the suscep-
tibility of individual TGF-β family members to proteolytic
cleavage. However, recent studies suggest that members of
the subtilisin-like proprotein convertase (SPC) family,
SPC1 and SPC4, could enhance the cleavage of BMP4 pre-
cursor. The availability of biologically active BMPs may
therefore be controlled by the released of their precursor
followed by the action of the proprotein convertases
[49,50].
The release by npMSCs of biologically-active form of
BMP4 which promotes astroglial differentiation and
inhibits oligodendroglial differentiation is consistent with
previous studies demonstrating that BMPs play multiple
roles in development [8]. Other studies have reported that
the effects of BMPs are age- and tissue-dependent [51,52]
and that BMPs promote astroglial differentiation and
inhibit oligodendroglial differentiation when applied to
cultures of cortical cells plated at E16 [23]. Likewise, brief
treatment with BMPs induces astroglial fate in cultured
neural precursors from embryonic mice [37] or in oli-
godendrocytes from newborn rats [51]. More recently,
Rajan et al. [41] demonstrated that BMP4 induces astro-
glial differentiation of E14 and adult cortical neural stem
cells from the subventricular zone when they are placed in
high density culture. In this case, BMP4 has a true instruc-
tive role as NSCs cultures were clonal. Beside the instruc-
tive effect of BMP4 on glial lineages, some studies
explained how BMP4 could act on astrocytic and
oligodendrocytic precursors. A study realised on cerebel-
lar primitive neurectodermal tumor cell line demon-
strated that a high concentration of BMP2 and BMP4
attenuate apoptosis [53]. BMP-mediated inhibition of oli-
godendrogenesis is controlled through the repression of
the former transcription factor olig2 known to be essential
for the oligodendrocytic development [54,55]. All of these
data suggest that BMP4 released by npMSCs selectively act
on astrocytic and oligodendrocytic progenitors. In our
experiments, we only demonstrate the anti-apoptotic
effect of npMSCs-conditioned medium but we didn't test
its possible instructive effect in clonal cultures. As BMP4,
present in a biologically-active form in npMSCs condi-
tioned medium, has been identified to be responsible of
the increase of astrocytes numbers by the immunoblock-
ing experiment and as it has been already demonstrated to
be instructive [41], one could hypothesise that, in our sys-
tem, the increase of astrocytes in response to npMSCs-
derived BMP4 is a consequence of both a anti-apoptotic
effect on GFAP-positive cells and also an instructive effect
on NSCs.
Conclusions
When considering the use of MSCs in cell replacement
strategies for the treatment of various neurological dis-
eases, it should be taken into account that those cells
could also influence the development host neural
precursors.BMC Neuroscience 2004, 5:33 http://www.biomedcentral.com/1471-2202/5/33
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Methods
Preparation and culture of rat mesenchymal stem cells 
(MSCs)
Adult rat bone marrow was obtained from femoral and
tibial bones by aspiration and was resuspended into 5 ml
of DEM (Invitrogen, Merelbeke, Belgium) [56]. Between
100 and 200 × 106 marrow cells were plated on 175-cm2
tissue culture flask in DEM/10% foetal bovine serum (Inv-
itrogen). After 24 hours, the non-adherent cells were
removed. When the rMSCs became confluent, they were
resuspended with 0.25% Trypsin and 1 mM EDTA and
then sub-cultured. Nestin expression by MSCs was
induced as described in [32].
Preparation and culture of mouse striatal neural 
progenitor and stem cells
Green C57BL/6 mice embryos (Jackson Immunoresearch
Laboratory, Inc., West Grove, USA) or NMRI mice were
used as a source of striatal neural progenitor and stem
cells. Green mouse express GFP under control of the β-
actin promoter [57]. The day of conception was deter-
mined by the presence of a vaginal plug (embryonic day
0). E16 striata were isolated and triturated in DEM/F12
(Invitrogen) with a sterile Pasteur pipette. The cell suspen-
sion was filtered with a 70 µm-mesh and viable cells were
estimated by trypan blue exclusion. The cells were plated
(1 × 106 cells/75-cm2 tissue culture flask) in DEM/F12
supplemented with EGF (20 ng/ml, Sigma) and B27 (Inv-
itrogen), a multi-component cell culture supplement
devoid of any growth factor. When the size of neuro-
spheres reached approximately 50 cells, they were dissoci-
ated into a single cell suspension by trituration and
replated in fresh culture medium. Neurospheres with a
maximum of 3 passages were used in this study.
Co-culture of MSCs and neurospheres
MSCs and neurospheres were plated on polyornithine
coated dishes for 5 days, in DEM/F12 containing only B27
supplement and were then processed for immunocyto-
chemical analysis as described below.
Culture of neurospheres in MSCs conditioned medium
MSCs were placed in DEM/F12 medium supplemented
with B27 (Invitrogen), during 3 days. The conditioned
media were then filtered with 0.22 µm-pore filter before
being replaced on plated neurospheres during 5 days.
Immunocytochemistry
The cultures were fixed with 4% (v/v) paraformaldehyde
for 15 minutes at room temperature and washed 3 times
in TBS buffer. They were then permeabilized in 1% Triton-
X100 (v/v) for 15 minutes and washed 3 times in TBS
buffer. Non-specific binding was blocked by a 1 hour
treatment in TBST (TBS buffer with 0.1% Tween) contain-
ing defatted milk powder (30 mg/ml). The cells were then
incubated for 1 hour at room temperature with either
anti-glial fibrillary acidic protein (GFAP, Dako, mouse
IgG, dilution 1:500), or Tuj1 (Molecular Probes, mouse
IgG, dilution 1:1000), or O4 (Chemicon, mouse IgM,
dilution 1:100) primary antibodies (diluted in blocking
buffer). After 3 washes in TBS, cells were then incubated
in FITC- or Cy5-conjugated anti-mouse IgG or IgM (Jack-
son Immunoresearch, 1:500) for 1 hour at room temper-
ature and in the dark. The nuclei were stained with
ethidium homodimer (0.2 µM, Sigma). The preparations
were then mounted in Fluoprep™ (Biomerieux; France)
and observed using a Bio-Rad MRC1024 laser scanning
confocal microscope. The fraction of positive cells was
determined by counting 10 non-overlapping microscopic
fields (±50 cells/field, ±3500 cells/experiments) for each
coverslip in at least three separate experiments (n then
corresponds to the number of coverslips).
BrdU and propidium iodide incorporation
After 24 hours or 3 days of culture, BrdU (20 µM, Sigma)
which is a S-phase marker, or propidium iodide (400 mg/
ml, Sigma) was added to the differentiating neurosphere
cultures for 18 hours before fixation and staining. Tuj1,
O4 and GFAP immuno-labellings were performed as
described above. For BrdU labelling, coverslips were then
post-fixed for 10 minutes in 4% (v:v) paraformaldehyde,
incubated in HCl 1 N for 20 minutes at 37°C, washed
with sodium perborate solution (50 mM, pH 8.5) and
finally incubated with an anti-BrdU antibody for 1 hour at
room temperature (Oxford, rat IgG, dilution 1:200) and
Cy-5-conjugated anti-rat antibody, 1 hour at room
temperature. The preparations were analysed as describe
above.
RNA extraction and quantitative RT-PCR analysis
Total RNA was prepared using the RNeasy total RNA puri-
fication kit (Qiagen, Westburg). For cDNA synthesis, ran-
dom hexamer primers (Invitrogen) were used to prime
reverse transcriptase reactions. The cDNA synthesis was
carried out using Moloney-murine leukemia virus (M-
MLV) Superscript II Reverse transcriptase (Invitrogen) fol-
lowing the manufacturer's instructions. Quantitative PCR
was carried out using standard protocols with Quantitec
SYBR Green PCR Kit (Qiagen). The PCR mix contained
SYBR Greeen Mix, 0.5 µM primers (Table 1), 1 ng DNA
template and nuclease free water to final volume of 25 µl.
PCR were performed on RotorGene RG-3000 (Corbett
Research) and analyzed with Rotorgene Software (Corbett
Research). The percentage of gene expression by npMSCs
was normalized in function of GAPDH gene expression
and compared to the gene expression by nestin-negative
MSCs that was considered as 100%. Each gene analysis
was realised on three different samples with two run/sam-
ple (we then provided 6 PCR analyses by target gene)BMC Neuroscience 2004, 5:33 http://www.biomedcentral.com/1471-2202/5/33
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Western Blot
After 72 hours of culture, the conditioned medium (1.5
ml) from cultures of neural progenitor cells, npMSCs and
nnMSCs were incubated with heparin sepharose CL-6B
(Amersham Biosciences, Belgium) at 4°C for 24 hours.
After centrifugation (700 × g), the supernatant was
removed and bound proteins were eluted in loading
buffer (glycerol 10% v/v; Tris 0.05 M pH 6.8; SDS 2%,
bromophenol blue and 2.5% v/v – mercaptoethanol) by
heating at 70°C for 10 minutes. The protein concentra-
tions of various samples were quantified using the "RC
DC Protein Assay" (Bio-Rad, Belgium) and equal protein
quantities were loaded in each lane in a 15% sodium
dodecyl sulfate polyacrylamide gel and electrophoresed.
Then the proteins were transferred to PVDF membrane
(Amersham Biosciences, Belgium) using a Trans-Blot
Semi-Dry Transfer apparatus (Bio-Rad). The membranes
were saturated with 3% gelatin (BioRad) during 1 hour at
37°C, then incubated for 1 hour with a monoclonal anti-
body against BMP4 (R&D, goat IgG, 0.1 µg/ml) or actin,
as control for protein loading (Sigma, mouse IgG 1:5 000)
at room temperature and then washed several times with
PBS-0.1% Tween. The membrane was then incubated in
Cy5-conjugated anti-goat IgG or anti-mouse IgG (Jackson
Immunoresearch, 1:2500) for 1 hour at room tempera-
ture, in the dark. After several washes in PBS, the mem-
branes were scanned using a Typhoon 9200 Scanner
(Amersham Biosciences) and subsequent analyses were
performed with ImageQuant Software (Amersham
Biosciences).
BMP4 neutralization
Neurospheres were plated on polyornithine-coated dishes
and incubated during 5 days in DEM/F12 medium
supplemented with B27 (Invitrogen) and previously con-
ditioned by npMSCs during 3 days or not. Anti-BMP4
antibody (R&D, 2 µg/ml) was added on day 1 of this
incubation.
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